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How are nascent iron-sulfur (Fe-S) clusters directed to specific recipient proteins? In this issue of Cell
Metabolism, Maio et al. (2014) show that the mitochondrial Fe-S cochaperone protein HSC20 guides nascent
Fe-S clusters based on a highly conserved motif, LYR, that exists in target proteins in different molecular
contexts.Iron-sulfur (Fe-S) clusters are composed
of nonheme iron and inorganic sulfide
(Rouault, 2012). These crucial prosthetic
groups are necessary for a wide variety
of protein functions including single
electron transfers, enzymatic catalysis,
and ‘‘on-off’’ switching in key metabolic
pathways (e.g., cellular iron metabolism)
(Rouault, 2012). Genetic disruptions
affecting key proteins involved in Fe-S
cluster biogenesis are now known to
cause an increasing number of human
diseases, such as Friedreich’s ataxia
and sideroblastic-like microcytic anemia
(Rouault, 2012).
Eukaryotic Fe-S biogenesis is largely
mitochondrial (Rouault and Tong, 2008),
and, in humans, the core Fe-S cluster as-
sembly machinery includes the cysteine
desulfurase, NFS1, and a binding partner,
ISD11. NFS1 facilitates the abstraction
of sulfur from cysteine (Ye and Rouault,
2010) (Figure 1A), which is then trans-
ferred to the ‘‘scaffold’’ protein, ISCU.
Iron is also delivered to ISCU, perhaps
by frataxin (Richardson et al., 2010).
Nascent Fe-S clusters are then trans-
ferred from the scaffold protein to various
recipient proteins via the concerted action
of cluster transfer and chaperone proteins
(Lill, 2009) (Figure 1A). Fe-S cluster
biogenesis appears to involve a dedi-
cated chaperone-cochaperone pair of
proteins that transfers nascent Fe-S
clusters from the primary scaffold, ISCU,
to specific recipient proteins (Rouault,
2012). Proteins involved in these activities
in mitochondria include the ATP-depen-
dent chaperone, HSPA9 (mtHSP70); and
a DNAJ type III cochaperone (HSC20 in
mammals) (Shan and Cortopassi, 2012;
Uhrigshardt et al., 2010) (Figure 1A).348 Cell Metabolism 19, March 4, 2014 ª201Despite knowledge of key players in
this process, how Fe-S clusters are
directed to specific proteins is one unre-
solved question in this field. In this issue
of Cell Metabolism, Maio et al. (2014)
have taken some important steps toward
answering this question. In fact, they
show that the mitochondrial Fe-S cocha-
perone protein, HSC20, guides nascent
Fe-S clusters based, in part, on a highly
conserved LYR motif in target proteins.
These investigators not only provide
some long-sought answers to the logis-
tics of Fe-S cluster delivery but also
shed light on the assembly pathway of
complex II (i.e., succinate dehydroge-
nase) of the respiratory chain.
The authors embark on a mission to
determine the molecular ‘‘signature’’ that
guides HSC20 to recipient proteins. This
starts with a search for binding partners
of HSC20, using a stringent yeast two-
hybrid approach to screen a HeLa
cDNA library. Interestingly, while multiple
HSC20 binding partners were identified,
succinate dehydrogenase subunit B
(SDHB), the Fe-S cluster containing sub-
unit of complex II, appeared several
times. This intriguing result was confirmed
with two-way coimmunoprecipitation
experiments, demonstrating that HSC20
binds to SDHB (Figure 1B). Other notable
HSC20-interacting partners included
ISCU and HSPA9, the latter of which is
the recently identified cognate chaperone
binding partner of HSC20 (Figure 1B).
Maio et al. (2014) verified that SDHB
physically associates with the ISCU-
HSC20-HSPA9 complex that is impli-
cated in Fe-S cluster delivery (Figure 1B).
Using a series of elegant blue native-
PAGE experiments and mitochondrial4 Elsevier Inc.import assays, the authors further
demonstrated the existence of an assem-
bly intermediate of complex II (‘‘CIIb’’)
containing SDHB and the ISCU-HSC20-
HSPA9 complex. Knockdown experi-
ments further showed that both HSC20
and HSPA9 are required for complex II
assembly and activity. These results are
significant in that they add to the relatively
short list of protein factors known to be
required for complex II assembly. Addi-
tionally, they strongly suggest that during
complex II assembly SDHB acquires
its Fe-S clusters before it associates
with SDHA, the flavin-containing subunit
(Figure 1B). Indeed, previous studies
in yeast had determined that the SDHB
ortholog, Sdh2, only associates with the
SDHA ortholog, Sdh1, after flavinylation
of the latter (Kim et al., 2012).
Upon close examination of the SDHB
sequence, the authors identified two
leucine/tyrosine/arginine (LYR)-like mo-
tifs—specifically, L(I)YR motifs, in which
an isoleucine can substitute for leucine—
that are highly conserved within eukary-
otes and prokaryotes. The LYR family
consists of proteins of diverse functions
that typically carry this tripeptide motif
in the N-terminal region, and Rouault
and colleagues earlier identified that
the LYR protein ISD11 as an NFS1 bind-
ing partner that is involved in Fe-S
biogenesis (Shi et al., 2009). Notably,
while the significance of the LYR motif
to Fe-S biogenesis was unknown at
that time, Maio et al. (2014) have now
determined that these LYR motifs in
SDHB are responsible for binding the
C-terminal domain of HSC20 and thereby
engaging the Fe-S cluster transfer appa-
ratus (Figure 1B). Interestingly, en bloc
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Figure 1. Basic Mammalian Fe-S Cluster Biogenesis and the Roles of HSC20 and LYR Motifs
(A) Mitochondrial Fe-S cluster biogenesis in mammals. Iron-sulfur (Fe-S) clusters are assembled on the Fe-S cluster assembly scaffold protein (ISCU). ISCU binds
to the cysteine desulfurase, NFS1, which forms a dimer and removes sulfur from cysteine (Cys), providing the sulfur necessary for Fe-S cluster synthesis. It is not
clear how Fe is delivered to ISCU, although frataxin may be involved. Moreover, redox proteins, such as glutaredoxin 5 and ferredoxin, are believed to provide
electrons to nascent Fe-S clusters that facilitate their rearrangement on the ISCU scaffold (Rouault, 2012). After Fe-S clusters are assembled, the DNAJ type
cochaperone HSC20 binds to ISCU, and, in turn, this complex binds an ATP-dependent HSPA9 chaperone. The newly synthesized Fe-S clusters are then trans-
ferred from ISCU to recipient apo-proteins to convert them to their holoform with the help of various chaperones and/or accessory proteins.
(B) The role of HSC20 and LYR motifs in guiding Fe-S clusters to SDHB. Fe-S clusters assembled on the ISCU scaffold are transferred to the Fe-S protein, suc-
cinate dehydrogenase subunit B (SDHB), by a chaperone-cochaperone system. In the SDHB sequence, two LYR motifs and the KKX7KK consensus sequence
bind to HSC20 to engage the ISCU-HSC20-HSPA9-complex and aid the incorporation of three Fe-S clusters. Moreover, the accessory protein SDHAF1 binds
both HSC20 via a LYR site and SDHB via a non-LYR binding site, facilitating the delivery of the Fe-S cluster from ISCU to SDHB. Upon acquisition of three Fe-S
centers, SDHB forms one of the four subunits in complex II (succinate dehydrogenase).
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LYR motif alone is not sufficient for
HSC20 binding, and, thus, the molecular
context (e.g., secondary structure) sur-
rounding the LYR motif must also be
important. However, the LYR motifs
were necessary for SDHB binding in spe-
cific regions of the SDHB polypeptide
chain. In fact, their removal prevented
the association of SDHB with the Fe-S
cluster transfer apparatus and thereby
prevented the subsequent association
of SDHB with the SDHA subunit of
complex II.
The authors also discovered a third
binding site for HSC20 in the SDHB
sequence. This binding site comprises a
KKX7KK sequence and is located at the
C-terminal end of SDHB (Figure 1B).
While the functional significance of thisHSC20 binding site is unclear, similar se-
quences are present in the C-terminal
ends of two other proteins (i.e., glutare-
doxin 5 and SUCLG2) that the authors
identify as HSC20 binding partners.
An additional significant finding was
that succinate dehydrogenase assembly
factor 1 (SDHAF1), which participates in
complex II assembly, binds to SDHB
through a non-LYR site. This is significant,
as the authors observed that HSC20
bound to SDHAF1, probably through its
LYR site, suggesting that SDHAF1 may
initially dock with SDHB and thereby
facilitate HSC20 binding to SDHB and/or
perhaps other Fe-S cluster transfer
complexes that are bound at the LYR
binding sites on SDHB (Figure 1B). Thus,
the LYR motif may represent a ‘‘guiding
beacon’’ for HSC20 that allows clientCell Metabolismdiscrimination in the targeted delivery of
Fe-S clusters to recipient proteins.
In conclusion, the study of Maio et al.
(2014) has opened a treasure trove
of previously unrecognized interactions
among proteins that are key to the assem-
bly of complex II. These findings will likely
have implications for the acquisition of
Fe-S clusters by other proteins, including
key components of complex I, which re-
quires eight Fe-S clusters, and complex
III, which contains a noncanonical Fe-S
protein (i.e., the Rieske protein) that
acquires its Fe-S cluster in a manner
dependent on the assembly factor,
LYRM7, which bears the same LYRmotif.
In fact, the authors determined that
HSC20 bound to LYRM7. In a broader
sense, their results suggest that other
recently identified chaperone proteins in19, March 4, 2014 ª2014 Elsevier Inc. 349
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Previewsiron metabolism (e.g., the PCBPs), and
perhaps the metabolism of other transi-
tion metals, may be guided by simple
molecular signatures that are yet to be
discovered.
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Tumors display distinct metabolic programs, and altered lipid metabolism is emerging as an important pro-
cess in cancer. In this issue, Yue et al. (2014) report that aberrant cholesteryl ester accumulation is found in
advanced prostate cancers with PTEN loss and PI3K/AKT activation. Importantly, inhibition of cholesterol
esterification impaired cancer aggressiveness.Cancer cells frequently display alterations
in their metabolic activity compared to
their nontumorigenic counterparts. The
most prominent of these is the Warburg
effect, whereby cancer cells consume
higher amounts of glucose even in the
presence of molecular oxygen (aerobic
glycolysis). Additionally, cancer cells un-
dergo changes in their metabolic activity
to facilitate biomass accumulation and
anabolic growth. These include alter-
ations in lipid metabolism orchestrated
by the sterol regulatory element-binding
protein (SREBP) transcription factors,
which regulate genes involved with fatty
acid (FA) and cholesterol biosynthesis
(Currie et al., 2013). Increased activity of
SREBP and overexpression of its down-
stream targets has been reported in
several cancers, and ablation of SREBP
has been shown to impair growth of glio-
blastoma cells (Griffiths et al., 2013; Guoet al., 2009). Furthermore, particular com-
ponents of the de novo lipogenic machin-
ery, such as fatty acid synthase (FASN),
are upregulated in several cancers, asso-
ciated with the overexpression of known
oncogenes, and have been the focus
of substantial drug development efforts,
highlighting the desirability and tracta-
bility of targeting lipid metabolism in
cancer. Yue et al. (2014) add to
this by providing a novel quantitative
approach to classifying prostate cancers
based on cholesteryl ester (CE) accu-
mulation and that CE storage poten-
tiates PI3K-dependent SREBP activity,
thereby fueling cancer aggressiveness.
Crucially, this process can be exploited
therapeutically.
The detection of lipid metabolism in
cancer cells, particularly in intact tissues,
represents a technical challenge. Lipids
exist in different subcellular compart-ments, such as lipid droplets (LDs),
cellular organelles consisting of triacylgly-
cerides, sterols and phospholipids that
are crucial for the storage and hydrolysis
of neutral lipids. Utilizing label-free
Raman spectromicroscopy to quantita-
tively investigate LD composition at the
single cell level, Yue et al. (2014) revealed
an accumulation of CEs in high-grade and
metastatic prostate cancers but not in
normal prostate, benign prostatic hyper-
plasia (BPH), prostatitis, or prostatic intra-
epithelial neoplasia (PIN) specimens.
Accurate patient stratification, by identi-
fying those who require further interven-
tion and establishing which therapies will
be most efficacious, is an important step
in successfully treating cancer. The au-
thors demonstrate that CE accumulation
could be utilized to accurately identify
patients who require further treatment,
as it is a better predictivemarker of cancer
